<h2>I. Suspension and Resumption of Trading</h2>
<ol>
<li>
JFM Technologies: The company plans to acquire the controlling rights of Sichuan Yichong Technology Co., Ltd. and raise matching funds. As the transaction is expected to constitute a major asset restructuring and related party transaction, the stock will be suspended from trading starting tomorrow.
</li>
<li>
Keyuan Pharmaceutical: The company plans to acquire 99.42% equity of Shandong Hongjitang Pharmaceutical Group Co., Ltd. The stock will resume trading from October 22, 2024.
</li>
</ol>
<h2>II. Mergers and Acquisitions</h2>
<ol>
<li>
FAW Fuwei: Intends to transfer 6.4421% equity of FAW Finance to FAW Group. This transaction constitutes a related party transaction and a major asset restructuring.
</li>
<li>
Jiangtian Chemical: Intends to acquire 100% equity of Sandaya. Sandaya and Jiangtian Chemical both belong to the industry of chemical raw materials and chemical products manufacturing. Through this transaction, Jiangtian Chemical will add a high water-absorbent resin business.
</li>
<li>
Sino-UK Technology: Plans to acquire 55% equity of Suzhou Botemeng, with the target company's overall valuation ranging from 1.3 billion to 1.6 billion yuan.
</li>
</ol>
<h2>III. Equity Transfer, Repurchase, and Private Placement</h2>
<ol>
<li>
CR Material: The Chairman proposes to repurchase shares worth 60 million to 110 million yuan.
</li>
<li>
Trust Group: The largest shareholder plans to publicly solicit the transfer of 25.54% of shares.
</li>
<li>
Fengshen Co.: Plans to raise funds not exceeding 300 million yuan through a simple process of issuing shares to specific targets.
</li>
</ol>
Hong Kong Stock Market
<ol>
<li>
Miniso: Spent 1.15 million Hong Kong dollars on repurchasing 36,400 shares on October 18.
</li>
<li>
Kuaishou: Repurchased 257,800 shares today.
</li>
</ol>
<h2>IV. Increase and Decrease of Holdings</h2>
<ol>
<li>
Jiawei New Energy: Shareholders holding more than 5% intend to reduce their holdings by no more than 3%.
</li>
<li>
Weimai: Shareholder Cai Youliang reduced holdings by 1.6515 million shares, decreasing ownership to 5%.
</li>
<li>
Huifa Food: Shareholder Yang Hong plans to reduce holdings by no more than 2.4464 million shares, accounting for 1% of total share capital.
</li>
<li>
Tianyima: Dongxing Boyuan plans to reduce holdings by no more than 3.68% due to capital needs.
</li>
<li>
Huasen Pharmaceutical: Controlling shareholder plans to reduce holdings by no more than 3%.
</li>
<li>
Cosci Technology: Shareholder Liang Hongjian reduced holdings by 1.60%, decreasing ownership to 21.56%.
</li>
<li>
Maohua Shihua: Controlling shareholder plans to increase holdings by an amount not less than 10 million yuan.
</li>
<li>
Jiangzhong Pharmaceutical: Controlling shareholder plans to increase holdings by 60 million to 120 million yuan.
</li>
</ol>
Hong Kong Stock Market
<ol>
<li>IGG: Executive Director and Chief Operating Officer Xu Yuan increased holdings by 1 million shares, spending approximately 3.84 million Hong Kong dollars.</li>
</ol>
2. CR Pharma: Jiangzhong Pharmaceutical, the controlling shareholder, plans to increase holdings by 60 million to 120 million yuan.
3. COSCO SHIPPING Energy: Controlling shareholder China COSCO Shipping Group plans to increase A-shares holdings by 679 million to 1.358 billion yuan.
<ol>
<li>Alibaba: Reduced by approximately 5.194 billion Hong Kong dollars by JP Morgan.</li>
</ol>
<h2>V. Investment Cooperation and Business Operations</h2>
<ol>
<li>
SERES: Plans to use no more than 15 billion yuan of its own funds to purchase high-security, highly liquid, low-risk financial products to improve fund utilization efficiency and increase fund returns.
</li>
<li>
Nengke Technology: Wholly-owned subsidiary Nengke Ruiyuan signed a &#34;Large-scale Model Scenario Application Contract&#34; with a certain research institute limited company, with a total contract amount of 145 million yuan, accounting for 10.31% of the company's audited operating income for 2023.
</li>
<li>
Qiaoyin Shares: Signed a 497 million yuan contract for the Kaifeng project.
</li>
<li>
FAW Jiefang: Planning a major asset restructuring, intending to sell 21.84% equity of FAW Finance.
</li>
<li>
Sihuan Bio: The actual controller was investigated by the China Securities Regulatory Commission for violating information disclosure regulations.
</li>
<li>
CSSC Emergency: Under investigation for suspected illegal information disclosure.
</li>
</ol>
Hong Kong Stocks
<ol>
<li>
WuXi AppTec: Completed the issuance of $500 million zero-coupon guaranteed convertible bonds due in 2025, planned for global business development, etc.
</li>
<li>
Country Garden: The &#34;22 Bi Di 03&#34; first bondholders' meeting in 2024 passed the early redemption proposal.
</li>
<li>
Geely Auto: Acquired Ningbo Passenger Vehicle and signed a comprehensive service agreement.
</li>
<li>
Bank of China: Listed $300 million floating rate notes due in 2027 on the London Stock Exchange.
</li>
<li>
CITIC Securities: Sold the remaining equity and related shareholder loans of McDonald's China mainland and Hong Kong business.
</li>
<li>
Yango Group: The UK restructuring plan meeting is scheduled for November 22.
</li>
</ol>
<h2>VI. Performance Changes</h2>
<ol>
<li>
Juguang Technology: It is expected to achieve a profit of 110 million to 124 million yuan in the first three quarters of 2024, turning losses into profits year-on-year. The company's overall gross profit margin has increased compared to the same period last year.
</li>
<li>
Shangjin International: Net profit for the first three quarters of 2024 was 1.727 billion yuan, a year-on-year increase of 54.46%. The company's production and operation management capabilities steadily improved, with increased trade volume and sales volume and prices of mineral products.
</li>
<li>
Lihua Shares: Net profit for the first three quarters increased by 507.71% year-on-year.
</li>
<li>
Hangzhou Bank: Net profit for the first three quarters was 13.87 billion yuan, an 18.63% year-on-year increase.
</li>
<li>
Chuanning Bio: Net profit for the third quarter was 310 million yuan, a 24.20% year-on-year increase.
</li>
</ol>
Hong Kong Stocks
<ol>
<li>
ZTE: Achieved operating income of 27.557 billion yuan in the third quarter, a 3.94% year-on-year decrease, and a net profit of 2.174 billion yuan, an 8.23% year-on-year decrease.
</li>
<li>
China Mobile: Operating income for the third quarter was 244.7 billion yuan, a 0.1% year-on-year decrease; net profit attributable to equity shareholders of the parent company was 30.7 billion yuan, a 4.6% year-on-year increase.
</li>
<li>
Ping An of China: Net profit attributable to the parent company for the first three quarters was 119.182 billion yuan, a 36.1% year-on-year increase. Ping An's individual customers reached 240 million, with customers holding 4 or more contracts within the group accounting for 25.1%, and a retention rate of 98.0%
</li>
<li>
Lufax: Achieved operating income of RMB 5.54 billion in the third quarter. As of September 30, Lufax has served over 24.8 million borrowers.
</li>
<li>
Binhai Investment: In the third quarter, pipeline gas sales volume increased by 24% year-on-year
</li>
</ol>

000800

601127

000063

00763

On the evening of October 21st, SERES announced its plan to purchase financial products not exceeding 15 billion, while FAW Jiefang intends to sell 21.84% of its equity. ZTE's operating income in the third quarter was 27.557 billion yuan, a year-on-year decrease of 3.94%, with a net profit of 2.174 billion yuan, a year-on-year decrease of 8.23%. Several companies are involved in major asset restructurings, equity transfers, and repurchases, including JFMoyuan, Koyuan Pharmaceutical, and FAW Fuwei

- Several companies are undergoing significant transactions, including stock suspensions and resumption of trading due to major asset restructurings.  
- Notable activities include Jingfeng Mingyuan's planned acquisition of Sichuan Yichong Technology and Keyuan Pharmaceutical's purchase of Shandong Hongjitang's 99.42% stake.  
- Additionally, various firms are engaging in share buybacks, transfers, and reporting substantial profit increases for the third quarter of 2024.

Wallstreetcn

FAW Jiefang

SERES

Announcement on the evening of October 21st | SERES plans to purchase financial products not exceeding 15 billion; FAW Jiefang plans to sell 21.84% equity of FAW Finance